BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36242092)

  • 21. DNA-Targeted Inhibition of MGMT.
    Marsoner T; Schmidt OP; Triemer T; Luedtke NW
    Chembiochem; 2017 May; 18(10):894-898. PubMed ID: 28177192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repair of O(6)-methylguanine is not affected by thymine base pairing and the presence of MMR proteins.
    Lips J; Kaina B
    Mutat Res; 2001 Nov; 487(1-2):59-66. PubMed ID: 11595409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O(6)-methylguanine-DNA methyltransferase (MGMT): impact on cancer risk in response to tobacco smoke.
    Christmann M; Kaina B
    Mutat Res; 2012 Aug; 736(1-2):64-74. PubMed ID: 21708177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulating MGMT expression through interfering with cell signaling pathways.
    Bai P; Fan T; Wang X; Zhao L; Zhong R; Sun G
    Biochem Pharmacol; 2023 Sep; 215():115726. PubMed ID: 37524206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide.
    Brawanski KR; Sprung S; Freyschlag CF; Hoeftberger R; Ströbel T; Haybaeck J; Thomé C; Manzl C; Birkl-Toeglhofer AM
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated mutations in O⁶ -methylguanine DNA-methyltransferase (MGMT) reduce DNA repair functionality.
    Lamb KL; Liu Y; Ishiguro K; Kwon Y; Paquet N; Sartorelli AC; Sung P; Rockwell S; Sweasy JB
    Mol Carcinog; 2014 Mar; 53(3):201-10. PubMed ID: 23065697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma.
    Hong B; Yang E; Su D; Ju J; Cui X; Wang Q; Tong F; Zhao J; Yang S; Cheng C; Xin L; Xiao M; Yi K; Zhan Q; Ding Y; Xu H; Cui L; Kang C
    Neuro Oncol; 2024 Jan; 26(1):100-114. PubMed ID: 37651725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KDM6B promotes PARthanatos via suppression of O6-methylguanine DNA methyltransferase repair and sustained checkpoint response.
    Yang M; Wang C; Zhou M; Bao L; Wang Y; Kumar A; Xing C; Luo W; Wang Y
    Nucleic Acids Res; 2022 Jun; 50(11):6313-6331. PubMed ID: 35648484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).
    Cabrini G; Fabbri E; Lo Nigro C; Dechecchi MC; Gambari R
    Int J Oncol; 2015 Aug; 47(2):417-28. PubMed ID: 26035292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
    Schwartz S; Szeto C; Tian Y; Cecchi F; Corallo S; Calegari MA; Di Bartolomeo M; Morano F; Raimondi A; Fucà G; Martinetti A; De Pascalis I; Martini M; Belfiore A; Milione M; Orlandi A; Barault L; Barone C; de Braud F; Di Nicolantonio F; Benz S; Hembrough T; Pietrantonio F
    Eur J Cancer; 2019 Jan; 107():164-174. PubMed ID: 30579113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma.
    Zapanta Rinonos S; Li T; Pianka ST; Prins TJ; Eldred BSC; Kevan BM; Liau LM; Nghiemphu PL; Cloughesy TF; Lai A
    J Neurooncol; 2024 Jan; 166(1):129-142. PubMed ID: 38224404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors.
    Jackson CB; Noorbakhsh SI; Sundaram RK; Kalathil AN; Ganesa S; Jia L; Breslin H; Burgenske DM; Gilad O; Sarkaria JN; Bindra RS
    Cancer Res; 2019 Sep; 79(17):4331-4338. PubMed ID: 31273061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency.
    Montaldi AP; Lima SCG; Godoy PRDV; Xavier DJ; Sakamoto-Hojo ET
    Oncol Rep; 2020 Nov; 44(5):2275-2287. PubMed ID: 32901889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase.
    Lavon I; Fuchs D; Zrihan D; Efroni G; Zelikovitch B; Fellig Y; Siegal T
    Cancer Res; 2007 Sep; 67(18):8952-9. PubMed ID: 17875738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temozolomide analog PMX 465 downregulates MGMT expression in HCT116 colorectal carcinoma cells.
    Yang Z; Wei D; Liu F; Liu J; Wu X; Stevens MFG; Bradshaw TD; Luo Y; Zhang J
    J Cell Biochem; 2018 Jul; 119(7):5350-5358. PubMed ID: 29331023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma.
    Zhao J; Yang S; Cui X; Wang Q; Yang E; Tong F; Hong B; Xiao M; Xin L; Xu C; Tan Y; Kang C
    Neuro Oncol; 2023 May; 25(5):857-870. PubMed ID: 36272139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical appraisal of MGMT in digestive NET treated with alkylating agents.
    de Mestier L; Couvelard A; Blazevic A; Hentic O; de Herder WW; Rebours V; Paradis V; Ruszniewski P; Hofland LJ; Cros J
    Endocr Relat Cancer; 2020 Oct; 27(10):R391-R405. PubMed ID: 32698158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temozolomide Induces the Acquisition of Invasive Phenotype by O6-Methylguanine-DNA Methyltransferase (MGMT)
    Kochanowski P; Catapano J; Pudełek M; Wróbel T; Madeja Z; Ryszawy D; Czyż J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioblastoma with high O6-methyl-guanine DNA methyltransferase expression are more immunologically active than tumors with low
    Kushihara Y; Tanaka S; Kobayashi Y; Nagaoka K; Kikuchi M; Nejo T; Yamazawa E; Nambu S; Kugasawa K; Takami H; Takayanagi S; Saito N; Kakimi K
    Front Immunol; 2024; 15():1328375. PubMed ID: 38288307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to Temozolomide.
    Nakagawa-Saito Y; Mitobe Y; Togashi K; Suzuki S; Sugai A; Kitanaka C; Okada M
    Anticancer Res; 2023 Mar; 43(3):1131-1138. PubMed ID: 36854532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.